Dana Matzen
Net worth: 14 960 $ as of 2024-03-30
Profile
Dana Matzen worked as Director of Business Development at Paladin Labs, Inc. from 2010 to 2016.
From 2016 to 2023, she served as Vice President of Business and Corporate Development at Intelgenx Corp.
and IntelGenx Technologies Corp.
respectively.
Matzen holds a graduate degree from the University of Kiel and a doctorate from Technische Universität Wien.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-01-28 | 85,000 ( 0.05% ) | 14 960 $ | 2024-03-30 |
Former positions of Dana Matzen
| Companies | Position | End |
|---|---|---|
Intelgenx Corp.
 Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Corporate Officer/Principal | 2023-03-09 |
| INTELGENX TECHNOLOGIES CORP. | Corporate Officer/Principal | 2023-02-28 |
| PALADIN LABS INC. | Corporate Officer/Principal | 2016-02-29 |
Training of Dana Matzen
| University of Kiel | Graduate Degree |
| Technische Universität Wien | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| INTELGENX TECHNOLOGIES CORP. | Health Technology |
| Private companies | 2 |
|---|---|
Paladin Labs, Inc.
 Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Paladin Labs Inc. operates as pharmaceutical company. It engages in developing, acquiring, in-licensing, marketing, and distributing innovative pharmaceutical products in Canada and internationally. The firm's products include Abstral, GlucaGen, Metadol, Plan B, Pennsaid, Seasonale, Testim, Twinject, Dexedrin, Tridural, and Trelstar. The company was founded by Jonathan Ross Goodman and Mark Beaudet on February 25, 1983 and is headquartered in Montreal, Canada. | Health Technology |
Intelgenx Corp.
Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada. | Health Technology |
- Stock Market
- Insiders
- Dana Matzen
